Stenotrophomonas maltophilia is an emerging nosocomial pathogen more and more often responsible for respiratory tract infections. It is intrinsically resistant to numerous antibiotics, making it potentially challenging to treat. The debate between combination therapy (CT) and monotherapy (MT) continues. Microbiological data and some clinical data concerning bacteremia seem to be in favour of CT...
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.